Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 18 citing Larsson: Activated protein C resistance in patients with central retinal vein occlusion. (0.08 sec) 

Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion.


O Tekeli, E Gürsel, H Buyurgan - Acta Ophthalmologica Scandinavica, 1999 - ncbi.nlm.nih.gov
PURPOSE: The role of decreased levels of protein C, protein S and antithrombin
III were investigated in patients with branch and central retinal vein
occlusion. METHODS: Forty-five patients with retinal vein occlusion and 20 ...
Cited by 35 - Related articles - All 4 versions

Hematologic abnormalities associated with various types of retinal vein occlusion


S Hayreh, BM Zimmerman, P Podhajsky - Graefe's Archive for Clinical and Experimental …, 2002 - Springer
Abstract Background: The objec- tive of this study was two-fold: (1) to
investigate hematologic abnormali- ties associated with various types of retinal
vein occlusion (RVO) and comparison of their prevalence among those various ...
Cited by 31 - Related articles - BL Direct - All 3 versions

High prevalence of resistance to APC in young patients with retinal vein occlusion


C Kuhli, LO Hattenbach, I Scharrer, F Koch, C … - Graefe's Archive for Clinical and Experimental …, 2002 - Springer
Abstract Resistance to activated protein C (APC) is among the coagu- lation
disorders that have been impli- cated in retinal vein occlusion. How- ever,
since retinal vascular occlu- sions may be due to a combination of several ...
Cited by 21 - Related articles - BL Direct - All 3 versions

Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch …


D Kalayci, A Gürgey, D Güven, H Parlak, H … - Acta Ophthalmologica Scandinavica, 1999 - ncbi.nlm.nih.gov
PURPOSE: The role of factor V Leiden and prothrombin 20210 A mutations has been
investigated in patients with central retinal vein occlusion (CRVO), hemispheric
retinal vein occlusion (HRVO), and branch retinal vein occlusion (BRVO). ...
Cited by 20 - Related articles - All 4 versions

Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive …

- nih.gov [PDF] 
M Chak, GR Wallace, EM Graham, MR … - British Journal of Ophthalmology, 2001 - bjo.bmj.com
Venous thrombosis affects one in 1000 individuals per year1 2 causing
significant morbidity and mortality. Inherited thrombophilia is a genetically
determined tendency to thrombosis. Dominant abnormalities or combinations ...
Cited by 17 - Related articles - BL Direct - All 6 versions

Is activated factor VII associated with retinal vein occlusion?

- nih.gov [PDF] 
S Kadayifçilar, D Özatli, OI Özcebe, E Cumhur … - British Journal of Ophthalmology, 2001 - bjo.bmj.com
METHODS 54 consecutive cases with RVO seen between March and September 1999 were
included in the study. 22 cases had central retinal vein occlusion (CRVO) and 32
had branch retinal vein occlusion (BRVO). Ophthalmoscopic examination with ...
Cited by 16 - Related articles - BL Direct - All 8 versions

Influence of factor V Leiden on the development of neovascularisation secondary to central …

- bmj.com
C Hvarfner, A Hillarp, J Larsson - British Medical Journal, 2003 - bjo.bmj.com
Methods: 166 patients with CRVO were studied retrospectively. They were tested
for factor V Leiden using DNA analysis. The presence of the mutation was studied
in correlation with the development of neovascular complications 1 year ...
Cited by 11 - Related articles - BL Direct - All 7 versions

Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities

- nih.gov
J Rehak, M Rehak - Current Eye Research, 2008 - informahealthcare.com
In branch retinal vein occlusion (BRVO), abnormal arteriovenous crossing with
vein compression, degenerative changes of the vessel wall and abnormal
hematological factors constitute the primary mechanism of vessel occlusion. ...
Cited by 11 - Related articles - BL Direct - All 6 versions

Prevalence of factor V Leiden in patients with retinal vein occlusion.


FY Demirci, DB Güney, K Akarcay, N Kir, U … - Acta Ophthalmologica Scandinavica, 1999 - ncbi.nlm.nih.gov
PURPOSE: Factor V Leiden mutation is a common genetic defect associated with a
tendency to venous thrombosis. The aim of this study was to evaluate the
prevalence of factor V Leiden in patients with retinal vein occlusion ...
Cited by 9 - Related articles - All 4 versions

[PDF] The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly …


M Rehak, J Rehak, M Muller, S Faude, F … - THROMBOSIS AND HAEMOSTASIS-STUTTGART-, 2008 - imise.uni-leipzig.de
Summary Several small case-control studies have investigated whether factor V
Leiden (FVL) is a risk factor for retinal vein occlusion (RVO) and generated
conflicting data. To clarify this question we performed a large two-centre ...
Cited by 3 - Related articles - View as HTML - BL Direct - All 5 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google